A recent study suggests that diabetic patients who experience low blood sugar (also known as hypoglycemia) are at a higher risk of having a cardiovascular event and of dying from a cardiovascular event than those who do not experience low blood sugar.
The researchers used data from the UK Clinical Practice Research Datalink database. They found that people who experienced hypoglycemia were at a 60% higher risk of experiencing a cardiovascular event and were 2 to 2.5 times more likely to die than those who did not experience hypoglycemia.
They believe that this is because diabetics are at a higher risk of cardiovascular disease due to the formation of plaque in their blood vessels. Therefore, when their blood sugar drops, potentially fatal cardiovascular events can be triggered.
Researchers from the Imperial College London, the QIMR Berghofer Medical Research Institute and Novo Nordisk A/S conducted the study. It was published online ahead of print on December 9, 2014, in Diabetes Care.
People with diabetes get hypoglycemia (low blood sugar) when their bodies do not have enough sugar to use as fuel. Several things can cause hypoglycemia, including diet and some medications. Certain medical conditions can also make hypoglycemia more common in people with diabetes. Exercise may also trigger hypoglycemia.
Americans suffer 1 billion colds annually, which results in lost work hours every year. A recent study suggests that taking a daily supplement of French maritime pine bark (Pycnogenol®) may shorten the duration of the common cold as well as reduce the severity of sore throat, congestion, headache, coughing and sneezing.
Participants in the study included 146 people between the ages of 25 and 65, none of whom had taken a flu vaccination within three months of the beginning of the study. As soon as they started to show cold symptoms, 70 of the participants decided to take 100 mg of Pycnogenol® in addition to their usual cold treatments while the other 76 just followed their usual cold treatments.
Within four days of showing the first symptom, the Pycnogenol® group had an average 1.1 fewer days affected by cold and an average reduction of 0.12 days in the number of lost work days.
The researchers also noted that the Pycnogenol® group was less likely to ask for additional treatments such as nasal drops, aspirin plus vitamin C, antihistamines, and aerosols when compared with the control.
Researchers from Cheiti-Pescara University in Italy conducted the study. It was published in the December 2014 issue of Panminerva.
Pycnogenol® has been shown to help with high blood pressure, muscle soreness, osteoarthritis, diabetes, attention deficit-hyperactivity disorder, endometriosis, menopausal symptoms, ringing in the ears, erectile dysfunction and retinopathy.